Harvey Feldman

hfeldman

Harold Feldman, MD, MSCE is the Chair of the Department of Biostatistics and Epidemiology (DBE), the George S. Pepper Professor of Public Health and Preventive Medicine, a Professor of Biostatistics and Epidemiology, Medicine (Renal Electrolyte and Hypertension Division), and Medicine in Pediatrics, and the Director of the Center for Clinical Epidemiology and Biostatistics (CCEB).  Dr. Feldman earned his MD in 1982 from Boston University before completing a residency in Internal Medicine at the University of California, Los Angeles.  He subsequently completed a fellowship in nephrology at the University of Pennsylvania where he also trained in Clinical Epidemiology.  His work has also been recognized through membership in the American Society of Clinical Investigation, the Association of American Physicians, and the American Epidemiological Society.  He is President-elect of the American College of Epidemiology.

Among his numerous national leadership roles, Dr. Feldman leads NIH’s Chronic Renal Insufficiency Cohort Study (CRIC), the major national research effort making fundamental insights into the epidemiology, management, and outcomes of chronic kidney disease. Under his leadership, the CRIC Study has discovered numerous findings with great promise to advance the development of novel therapies to reduce morbidity in this population worldwide.  Dr. Feldman also leads NIDDK’s Hemodialysis Fistula Maturation Cohort Study and the Coordinating Center of its Chronic Kidney Disease Biomarkers Consortium.  Dr. Feldman is the director of multiple NIH-funded institutional training grants in the clinical epidemiology of kidney disease, cancer, and neurological disorders. He is a past inaugural Deputy Editor of the Clinical Journal of the American Society of Nephrology as well as a past Associate Editor of the Annals of Internal Medicine. He is incoming Editor-in-Chief of the American Journal of Kidney Disease.  Dr. Feldman’s published scholarship of more than 190 research publications has appeared in many leading biomedical journals.